⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15832602 | 0.71 | — | — | |
| SCHEMBL17303005 | 0.70 | — | — | |
| SCHEMBL17154462 | 0.67 | — | — | |
| SCHEMBL15605883 | 0.65 | — | — | |
| SCHEMBL27574913 | 0.64 | — | — | |
| SCHEMBL17303079 | 0.64 | — | — | |
| SCHEMBL16152934 | 0.64 | — | — | |
| SCHEMBL14049576 | 0.63 | — | — | |
| SCHEMBL27951802 | 0.62 | — | — | |
| SCHEMBL13623876 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2242742-B1 | PYRIDINE DERIVATIVES | NOVARTIS AG (CH) | 2015-12-02 | — | — | EP | disclosed |